Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea
Asthma, Sleep Apnea

About this trial
This is an interventional treatment trial for Asthma focused on measuring Asthma, Sleep Apnea, Obesity, CPAP
Eligibility Criteria
Inclusion Criteria: Adult (>18yrs at the time of recruitment) Body mass index (BMI) ≥ 30 Symptoms suggestive of sleep apnea Epworth Sleepiness Score (ESS) within range Positive sleep study for sleep apnea Exclusion Criteria: Tobacco use within the last 3 months. Presence of other significant comorbid heart or lung disease Presence of another chronic inflammatory disease, such as connective-tissue disease, inflammatory bowel disease, or active infection. Use of systemic steroids, as defined as any prednisone use in the preceding 3 months. Use of leukotriene antagonists or theophylline within the preceding 6 weeks. Presence of severe or uncontrolled sinusitis, such that CPAP therapy will be difficult or uncomfortable. History of significant claustrophobia, uncontrolled psychiatric disease, or anticipated intolerance of CPAP therapy. Night shift workers, or other subjects with significantly altered sleep-wake cycles. Baseline post-bronchodilator FEV1 < 70% predicted. Severe gastroesophageal reflux disease.
Sites / Locations
- National Jewish Medical and Research Center